Skip to main navigation
  • Home
  • Synthetic Biology
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Bioticâ„¢ Medicines
  • Pipeline + Programs
    • Partner with Us
  • For Patients
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News & Events
      • News Releases
      • Events
      • In the News
    • Presentations & Publications
    • Stock Information
    • Corporate Governance
    • Financials
    • Investor Resources
explore the
possibilities

Synlogic Therapeutics

Investor Relations

SEC Filing Details

  • Home
  • Synthetic Biology
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Bioticâ„¢ Medicines
  • Pipeline + Programs
    • Partner with Us
  • For Patients
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News & Events
      • News Releases
      • Events
      • In the News
    • Presentations & Publications
    • Stock Information
    • Corporate Governance
    • Financials
    • Investor Resources

SEC Filing Details

Document Details

Form
DRS/A
Filing Date
Apr 4, 2014
Document Date
Apr 4, 2014
Form Description
mendment to a previously filed DRS
Filing Group
Registration Statements
Company
Synlogic
Issuer
SYNLOGIC, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • Email Alerts
  • Contact IR
  • RSS Feeds
  • Print Page
  • Email Page

Synlogic Therapeutics

Contact

Synlogic

301 Binney St #402
Cambridge, MA 02142

info@synlogictx.com
(617) 401-9975

  • Twitter
  • LinkedIn

Privacy and Terms

© 2022 Synlogic
Privacy Policy